文献速递外周动脉疾病

完成监督运动治疗与间歇性跛行合并肌少症及心脏代谢多病共存患者长期结局的关联

The Association Between Completion of Supervised Exercise Therapy and Long-Term Outcomes in Patients with Intermittent Claudication, Concomitant Sarcopenia, and Cardiometabolic Multimorbidity.
PubMed 文献 · Ann Vasc Surg · 2024-07-25

该注册研究纳入2014至2017年转诊接受监督运动治疗的间歇性跛行合并心脏代谢多病共存及肌少症患者82例,其中26例完成监督运动治疗、56例拒绝或提前中止。完成监督运动治疗与进展至慢性威胁肢体缺血风险降低(HR 0.23)及主要不良肢体事件风险降低(HR 0.21)相关,但主要不良心血管事件风险无显著降低(HR 0.88)。

要点

  • 完成监督运动治疗与进展至慢性威胁肢体缺血风险降低相关(HR 0.23)。
  • 完成监督运动治疗与主要不良肢体事件风险降低相关(HR 0.21)。
  • 完成监督运动治疗与主要不良心血管事件风险无显著降低相关(HR 0.88)。

核心结论

  • 完成监督运动治疗与间歇性跛行合并肌少症及心脏代谢多病共存患者不良肢体结局的显著改善相关。

研究设计与样本

  • 注册研究回顾性分析2014至2017年转诊接受监督运动治疗的连续间歇性跛行合并心脏代谢多病共存及肌少症患者82例,其中56例拒绝或提前中止监督运动治疗、26例完成监督运动治疗。
  • 心脏代谢多病共存定义为糖尿病、心脏病、卒中或慢性肾脏病中2种及以上共存。
  • 肌少症采用此前18个月内CT扫描的L3骨骼肌指数评估。

主要发现

  • 完成监督运动治疗与进展至慢性威胁肢体缺血风险降低相关(HR 0.23;95%CI 0.07-0.69;P=0.02)。
  • 完成监督运动治疗与主要不良肢体事件风险降低相关(HR 0.21;95%CI 0.057-0.775;P=0.02)。
  • 完成监督运动治疗与主要不良心血管事件风险无显著降低相关(HR 0.88;95%CI 0.423-1.629;P=0.73)。
  • 两组基线特征及L3骨骼肌指数无显著差异。
  • 模型显示良好预测准确性(Harrell's C指数>0.6)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: The combination of intermittent claudication (IC), cardiometabolic multimorbidity (CMM), and sarcopenia is associated with worse outcomes than IC alone. This study aimed to identify whether the completion of supervised exercise therapy (SET) attenuates these adverse outcomes in patients with combined IC, sarcopenia, and CMM. METHODS: This registry review included consecutive IC patients with concomitant CMM and sarcopenia, who were referred for SET from 2014 to 2017. CMM was defined as 2 or more comorbidities (diabetes, heart disease, stroke, or chronic kidney disease). Sarcopenia was assessed using the L3-skeletal muscle index (L3SMI) from computed tomography (CT) scans in the preceding 18 months. The outcomes of interest were progression to chronic limb-threatening ischemia (CLTI), major adverse cardiovascular events (MACE), and major adverse limb events (MALE). Survival and Cox regression analyses were performed. RESULTS: Eighty-two patients with a combination of IC, CMM, and sarcopenia were included. Of these, 56 declined or prematurely discontinued SET and 26 completed SET. Baseline characteristics and L3SMI did not significantly differ between groups. Completion of SET was associated with slower progression to CLTI (HR: 0.23; 95% CI: 0.07-0.69; P = 0.02) and a reduced risk of MALE (HR: 0.21; 95% CI: 0.057-0.775; P = 0.02). However, there was no reduction in the risk of MACE (HR: 0.88; 95%CI: 0.423-1.629; P = 0.73). Models demonstrated good predictive accuracy (Harrell's C-index >0.6). CONCLUSIONS: Completion of SET was associated with significant improvements in adverse limb outcomes in patients with IC, concomitant sarcopenia, and CMM.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Ravindhran B, Igwe C, Prosser J, et al. The Association Between Completion of Supervised Exercise Therapy and Long-Term Outcomes in Patients with Intermittent Claudication, Concomitant Sarcopenia, and Cardiometabolic Multimorbidity. Ann Vasc Surg. 2024. PMID: 39067848. doi:10.1016/j.avsg.2024.04.032

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。